Advertisement

News

  • Early data suggest air pollution may initiate lung cancer

    Early data suggest air pollution may initiate lung cancer

    Researcher Peiyao Wang said early results show that fine particulate matter is causing permanent DNA damage, which could have implications for lung cancer screening.


  • Osimertinib plus chemo beat chemo alone in patients with advanced EGFR-mutated NSCLC who advanced on first-line osimertinib

    Osimertinib plus chemo beat chemo alone in patients with advanced EGFR-mutated NSCLC who advanced on first-line osimertinib

    Experts said the results of the COMPEL trial support continued treatment with osimertinib beyond progression in this patient population.


  • SOAR Act in limbo while legislators ride out government shutdown

    SOAR Act in limbo while legislators ride out government shutdown

    CHEST Past President John E. Studdard, MD, Master FCCP, said the biggest impact of Medicare competitive bidding has been reduced reimbursement, which has slowed innovation in oxygen delivery.


  • Study explores geographic disparities in tobacco dependence treatment among veterans with COPD

    Study explores geographic disparities in tobacco dependence treatment among veterans with COPD

    Study author Arianne K. Baldomero, MD, said that reducing geographic barriers will require multidisciplinary approaches and innovative, equitable health care solutions.


  • Latest data show peripheral vasopressors safer, quicker than central ports

    Latest data show peripheral vasopressors safer, quicker than central ports

    Results from a recent analysis of the CLOVERS trial demonstrated a similar 90-day mortality rate with fewer complications for vasopressors compared with central venous catheter administration for the management of sepsis-induced hypotension.


  • Viloxazine-trazodone combo shows promise for OSA relief

    Viloxazine-trazodone combo shows promise for OSA relief

    Investigator Ludovico Messineo, MD, PhD, said lower dosages will need to be tested to ensure that the beneficial effects on OSA severity are maintained while minimizing side effects.


  • Azelastine nasal spray shows promise in preventing SARS-CoV-2 infections

    Azelastine nasal spray shows promise in preventing SARS-CoV-2 infections

    Researcher Robert Bals, MD, PhD, said this is a starting point, a signal of efficacy that warrants confirmation in larger, multicentric, phase 3 trials.


  • No benefit found for conservative oxygen therapy for adults who are critically ill

    No benefit found for conservative oxygen therapy for adults who are critically ill

    While the approach did not outperform usual therapy, it was not inferior to standard treatment either, suggesting additional studies of SpO2 goals are warranted.


  • Asthma self-management app beats usual care for asthma control

    Asthma self-management app beats usual care for asthma control

    Researcher Jordan Silberman, MD, PhD, said the findings—which varied by race—underscore the need for culturally adaptive strategies to ensure equitable engagement across all populations.


  • Study identifies key environmental exposures associated with risk of interstitial lung disease

    Study identifies key environmental exposures associated with risk of interstitial lung disease

    Bradford C. Bemiss, MD, MSc, said the findings underscore the importance of asking patients about potential workplace inhalation exposures.